First-and-only FDA-approved solution formulation of this medication now available in 100 mcg per 5 mL, 200 mcg per 5 mL and 500 mcg per 5 mL single-dose vials LAKE ZURICH, Ill.--(BUSINESS ...

Please provide your email address to receive an email when new articles are posted on . A voluntary recall has been issued for an oral solution of levothyroxine sodium due to possible subpotency among ...

Yaral Pharma, the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a multinational pharmaceutical company headquartered in Lugano, Switzerland, are now the exclusive supplier of the ...

PHILADELPHIA, Nov. 3, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced the launch of the authorized generic of Tirosint® (Levothyroxine Sodium Capsules USP) ...

Fresenius Kabi has announced the availability of Levothyroxine Sodium Injection Solution in 100mcg per 5mL, 200mcg per 5mL and 500mcg per 5mL single-dose vials. Fresenius Kabi has announced the ...

On June 24, The U.S. Food and Drug Administration(FDA) rejected a citizen petition filed in August 2003 regarding bioequivalence of levothyroxine sodium products and approved first-time generic ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)-- APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S.

Hikma is offering levothyroxine sodium injection in ready-to-use vials in a 100 mcg/ml dose. Levothyroxine sodium is an important medicine used in hospitals for the treatment of myxedema coma. The ...

Add Yahoo as a preferred source to see more of our stories on Google. Prescribed to treat hypothyroidism and thyroid cancer, around 7% of the U.S. population takes levothyroxine. The drug is a ...

Credit: Getty Images. Tirosint is now available in 15 dosage strengths. IBSA Pharma announced the launch of Tirosint ® (levothyroxine sodium) gel capsules in 3 new dosage strengths: 37.5mcg, 44mcg, ...

NEW PROVIDENCE, N.J., Feb. 24, 2021 /PRNewswire/ -- Vertice Pharma ("Vertice"), a specialty pharmaceuticals company focused on improving patients' health, today announced the launch of THYQUIDITY.

Thirty-six volunteers (18 women and 18 men) between 19 and 50 years of age, inclusive, were enrolled. Subjects were clinically and biochemically euthyroid and in general good health based on the ...